Integrated Research on Acute Malnutrition in Chad

NCT04867694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2089

Last updated 2023-02-13

No results posted yet for this study

Summary

The IRAM Chad impact evaluation will be based on a cluster randomized controlled trial to study the impact of the integrated and multisectoral services package (PASIM), aimed at reducing the incidence and prevalence of wasting through integrated interventions, including, among other things, strengthening the activity of community care groups, food supplementation, water treatment, and screening for wasting conducted by families.

Conditions

  • Acute Malnutrition in Childhood
  • Wasting

Interventions

BEHAVIORAL

BCC

Behavior change communication on Nutrition, Health \& Hygiene, including (but not limited to) awareness of dietary diversification from 6 months of age and adequate complementary feeding; and raising awareness of good water and hygiene practices.

DIETARY_SUPPLEMENT

Preventive supplement

Monthly delivery of a nutritional supplement: enriched flour (CSB++), at a dose of 3 kg/month/beneficiary child. The nutritional supplement is limited to \[6-11\] months old children diagnosed as non-wasted (green MUAC); or children \[12-59\] months old for 6 months after discharge from a CMAM treatment or consolidation program.

DIETARY_SUPPLEMENT

MNP

Delivery of micronutrient powders to \[12-23\] months old children (30 sachets per month for 2 months, every 6 months, according to international recommendations).

OTHER

Water purification input

Monthly delivery of a water purification input: bleach or flocculant/decontamination sachets for the potabilization of the water of the whole household. The water treatment input is limited to households with \[6-11\] months old children, or children \[12-59\] months old enrolled in a CMAM treatment program and for 6 months after discharge.

BEHAVIORAL

Family MUAC

One-time delivery of a mid-upper arm circumference (MUAC) measuring tape and training of families in its use, and actions to be taken based on the results. This will involve distributing Shakir bands to all households with \[6-59\] months old children and training mothers/guardians, or any other family members who express an interest, in screening for wasting using the MUAC criteria, and explaining the procedure to follow if the child tests positive in the family. Formative supervision of MUAC measurement in families. The training will be carried out by the members of the care groups and at each home visit, they will be able to ensure that the MUAC measurement technique is well mastered by the mother (or another member) and correct the technique if necessary.

BEHAVIORAL

Screening by care group

Monthly screening by the care group volunteers of the children they follow, using the MUAC. Referral to the health center of \[6-59\] months old children screened as malnourished (result of MUAC orange or red), and follow-up on referral to confirm child was enrolled

BEHAVIORAL

CMAM compliance

Weekly follow-up of \[6-59\] months old children under treatment and for 6 months after discharge from the national treatment and consolidation program : care group volunteers follow children under treatment until they recover and for the whole duration of their consolidation (for children cured of severe emaciation) through weekly home visits. They monitor treatment adherence (i.e., families follow the planned schedule of visits and receive inputs for treatment or consolidation) and treatment compliance (i.e., the malnourished or consolidating child receives the planned dose of therapeutic or supplementary food each day).

Sponsors & Collaborators

  • UNICEF

    collaborator OTHER
  • Association Sahélienne de Recherches Appliquées pour le Développement Durable

    collaborator OTHER
  • ONG Moustagbal

    collaborator UNKNOWN
  • International Food Policy Research Institute

    lead OTHER

Principal Investigators

  • Lieven Huybregts, PhD · IFPRI

  • Elodie Becquey, PhD · IFPRI

  • Jef Leroy, PhD · IFPRI

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
23 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-03
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Chad

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04867694 on ClinicalTrials.gov